ReviewRadiologie (Heidelberg, Germany)2026
[Primary malignant bone tumours-part 1].
Review in Radiologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- NFS1 activates PI3K/AKT/mTOR signaling to upregulate GPX4 expression and enhance ferroptosis resistance in osteosarcoma.Functional & integrative genomics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary malignant bone tumours are rare (about 0.2% of all malignancies) whereby-according to age-both osteosarcoma and Ewing's sarcoma are the most frequent bone sarcomas in children and adolescents. Both sarcomas are highly-malignant tumours with poor prognosis (Ewing's sarcoma) in particular when metastasized (osteosarcoma). There is a broad diagnostic armamentarium available, allowing precise detection of such tumours. However, alertness and familiarity of (early) radiological signs (such as periosteal reactions) are prerequisites to arouse suspicion. Radiological methods (plain radiography, magnetic resonance imaging [MRI], computed tomography [CT], ultrasonography) will be discussed regarding their pathomorphological clues. Likewise, both use and significance of more advanced imaging modalities (dual-energy CT, photon-counting CT; the Dixon technique and MRI with ultrashort time-to-echo [TE] sequences) are reviewed.
Indexed as
Identifiers
41922581What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.